Ingevity Corporation NGVT
$68.25
-$1.16-1.67%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 21.74% | 1.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.74% | 1.14% | |||
| Cost of Revenue | 23.66% | -15.36% | |||
| Gross Profit | 19.42% | 32.57% | |||
| SG&A Expenses | -4.18% | -2.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.51% | -12.62% | |||
| Operating Income | 36.09% | 77.84% | |||
| Income Before Tax | 67.88% | 128.68% | |||
| Income Tax Expenses | 60.29% | 125.66% | |||
| Earnings from Continuing Operations | 70.09% | 129.70% | |||
| Earnings from Discontinued Operations | -112.36% | 727.59% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.97% | 170.69% | |||
| EBIT | 36.09% | 77.84% | |||
| EBITDA | 26.99% | 35.74% | |||
| EPS Basic | -40.00% | 171.57% | |||
| Normalized Basic EPS | 49.70% | 679.80% | |||
| EPS Diluted | -39.64% | 169.99% | |||
| Normalized Diluted EPS | 50.37% | 663.34% | |||
| Average Basic Shares Outstanding | -1.61% | -1.24% | |||
| Average Diluted Shares Outstanding | -2.05% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||